{"task_id": "6c25f74cd59bcf26", "source": "8205Oxford Handbook of Clinical Medicine 10th 2017 Edition_SamanSarKo - Copy.pdf (Part 430/905)", "text": ").\nCourtesy of Prof. S. Upton, \nKansas University.\n\n--- Page 436 ---\n422\nInfectious diseases\nVector-borne disease\nVector borne diseases are infections transmitted by the bite of infected arthropod \nspecies including mosquitoes, ticks, \ufb02 ies, and bugs (table 9.21).\nTable 9.21 Vector-borne disease\nVector/arthropod\nDisease\nPage\nMosquito Anopheles Malaria\n416\u20139\nAedes\nDengue, Chikungunya, yellow fever, Zika \n420\u20131\nCulex\nLymphatic \ufb01 lariasis, Japanese encephalitis, West Nile\n421,436\u20137\nTicks\nLyme disease, rickettsial disease, relapsing fever, tick-\nborne encephalitis, Crimean-Congo haemorrhagic fever\n422\u20133, \n426\u20137\nBugs/Flies\nLeishmaniasis, trypanosomiasis, onchocerciasis, loiasis\n423, 439\nSnails\nSchistosomiasis\n434\nLyme disease (Lyme borreliosis)\nTick-borne multisystem disease caused by the spirochaete Bor-\nrelia burgdorferi (or related Borrelia spp). ~All cases limited to \nnorthern hemisphere (mainly Europe and US). ~2000\u20133000 cases/\nyr in UK. Risk of infection from tick bite is 3\u201312% in Europe. Pres-\nentation: \ue007\u226475% remember the tick bite. Peak infection with \n48\u201372h of attachment. Disease stages:\n  \n\u2022 Early localized (3\u201330d after bite): erythema migrans (\ufb01 g 9.31), \npain/pruritus, lymphadenopathy, \u00b1 constitutional symptoms: \nfever, malaise, headache. \u2153 do not see a rash.\n  \n\u2022 Early disseminated (wks\u2013months): borrelial lymphocytoma \n= bluish-red plaque/nodule: check earlobes, nipples, genitals. \nNeuroborreliosis: lymphocytic meningitis, ataxia, amnesia, \nfacial/cranial nerve palsies, neuro pathy (severe pain, worse \nat night), encephalomyelitis. Carditis: acute onset 2nd/3rd-\ndegree heart-block, myocarditis.\n  \n\u2022 Late disseminated (months\u2013yr): acrodermatitis chronic atrophicans = focal in\ufb02 am-\nmation then atrophic skin; Lyme arthritis.\nDiagnosis: Clinical: erythema migrans with known exposure or evidence of infection. \nBorrelia culture (\ue001sensitivity: 40\u201370% for erythema migrans, <20% for CSF), PCR.4 Two-\ntier serology due to false-positive reaction with other spirochaete infection: enzyme \nimmunoassay/immuno\ufb02 uorescence + immunoblot. Sensitivity \ue001 due to slow serocon-\nversion: IgM 1\u20132wks (and may persist), IgG 4\u20136wks and background positivity 3\u201315%. \nTreatment: Erythema migrans: doxycycline 100mg BD PO for 10\u201321d (CI <8y, pregnant). \nAlternatives: amoxicillin, phenoxymethylpenicillin, azithromycin. Neuroborreliosis: cef-\ntriaxone or IV benzylpenicillin or doxycycline for 10\u201330d. Arthritis/carditis: doxycyline \nor amoxicillin or ceftriaxone for 14\u201330d.15 Prevention: Keep limbs covered; use insect re-\npellent (DEET); inspect skin and remove ticks (use tweezers, hold close to head/mouth).\nRickettsial disease\nRickettsiae are obligate, intracellular coccobacillary forms lying between bacteria \nand viruses. Mammals and arthropods are natural hosts. \ue000Risk with rural activities \neg camping, hiking, hunting. Divided into:\n  \n\u2022 Spotted fevers: eg Rocky Mountain spotted fever (Americas); rickettsialpox (\ue031\ue031 \nchicken-pox).\n  \n\u2022 Typhus: scrub typhus in Asia-Paci\ufb01 c regions; endemic (\ufb02 ea-borne) typhus in tropi-\ncal areas; epidemic (louse-borne) typhus in homeless populations, eg refugees.\n  \n\u2022 Other emerging illnesses: eg ehrlichia, anaplasma.\nPresentation: Incubation ~1\u20132wks. Fever, headache, malaise, rash (maculopapular, \nvesicular or petechial), N&V, myalgia. Check for local lymphadenopathy and an eschar \nat the site of the bite (scrub typhus). Wide variation in severity depending on aeti-\nology. Fulminant, life-threatening infection possible with Rocky Mountain spotted \nfever, louse-borne typhus, scrub typhus. Diagnosis: Clinical: fever + rash + travel to \nan endemic area. Serology, culture/PCR of blood/skin biopsy. Treatment: Antibiotics \nin severe cases: doxycycline, azithromycin, chloramphenicol.\nFig 9.31 Erythema \nmigrans: distinct ad-\nvancing edge.\nReproduced from \nLewis-Jones, Paedi-\natric Dermatology \n2010, with permission \nfrom Oxford University \nPress.\n4 Specialist diagnostic service and advice in UK via Rare and Imported Pathogens Laboratory (RIPL): www.\ngov.uk/government/collections/rare-and-imported-pathogens-laboratory-ripl", "text_length": 4097, "metadata": {"source": "8205Oxford Handbook of Clinical Medicine 10th 2017 Edition_SamanSarKo - Copy.pdf (Part 430/905)", "type": "chunk", "chunk_index": 429, "total_chunks": 905, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T17:59:52.912897", "document_uuid": "1c4b3c41-9a74-4d3d-ab11-d2a041c9641f", "filename": "8205Oxford Handbook of Clinical Medicine 10th 2017 Edition_SamanSarKo - Copy.pdf", "category": "medical_pdf", "section": "body", "year": 2017, "outdated": false, "document_id": "1c4b3c41-9a74-4d3d-ab11-d2a041c9641f"}, "created_at": "2025-12-11T17:59:52.913702", "status": "complete", "chunks_added": 3}